Plain-English translation of NCT05922540 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are building a large database of patients who have experienced ischemic stroke (the most common type of stroke, caused by a blood clot). By collecting blood, urine, and stool samples along with medical information and imaging scans, the study aims to find biological markers—early warning signs—that can predict how well someone will recover and what their long-term outlook might be.
Right now, doctors cannot reliably predict which stroke patients will have a good recovery and which will face lasting challenges. This research seeks to identify biological clues that could help doctors better predict outcomes and eventually develop better ways to prevent strokes before they happen.
You likely qualify if…
You likely don't qualify if…
You would visit the hospital multiple times over the study period to provide samples (blood, urine, and stool) and undergo standard imaging and clinical evaluations. Researchers would also collect information about your medical history, symptoms, and how you are recovering from your stroke. The study tracks patients over time to see how their health progresses and how the biological markers relate to their actual recovery.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
China
Sponsor
Xiangya Hospital of Central South University
Enrollment target
~5,000 participants
Started
November 2022
Primary completion
November 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2023.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.